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Summary 
Current techniques for laboratory diagnosis of tuberculosis 
have some serious l i t i o n s  These inetude the high cost and 
time required for the current assays. The development of a 
rapid, sensitive, specific and lewd assay is therefore of con- 
siderable importance. We rewrt here the develmment and labo- 
ratory testing of a polymerase chain reaction DNA-based 
diagnostic test for the presence of MyCObacterium tuberculosis 
in sputum. The assay shows a high level of sensitivity and 
specific@ and requires considerably less capital, consumables 
and time inputs than existing laboratory tests. We b e l i e  this 
technology is ready for largescale evaluation and use, particu- 
larly in hospital-based laboratories. 
In a country such as South Akica, which has a considerable 
Third-World component, many argue that we should not be 
doing high-tech research at all. In this debate, words such as 
relevance, need, affordability and applications are often heard. 
However, there are instances where high-tech research can be 
apphea to community health problems, an example of which is 
presented here: the rapid diagnosis of infectious diseases such 
as tuberculosis. 
Basic research has led to a detailed understanding of DNA 
synthesis and replication. Researchers have used this know- 
ledge to develop an in method for DNA synthesis, known 
as polymerase chain reaction (PCR),1,2 in which a specific frag- 
ment of DNA can be amplified, possibly a million-fold. While 
this technology was developed as an aid to basic research, it 
has been used for the diagnosis of infectious diseases including 
tuberculo~is.~~~ si^ 
Where existing methods are insensitive, provide only indi- 
rect evidence of infection (e.g. IgM), or require extended cul- 
ture (e.g. Mycobacterium tubernrlosis) PCR may prove useful. 
Since the PCR technique detects organism-specific DNA it 
can be used in both active and latent disease. It is very sensi- 
tive (detection limit as low as one ~rganism,~) highly specific, 
inexpensive and relatively rapid. The starting material can be 
any tissue or body fluid or even archival material (e.g. p& 
blocks). 
We report our use of this technology for detection of M. 
t u b d s i s  in patients presenting at Tygerberg Hospital, and 
propose that this is a good example of the use of a so-called 
high-tech method for obtaining a low-cost, valid diagnosis for 
a high-priority disease. 
Materials and methods 
Samples 
Samples £rom patients suspected of having tuberculosis 
were obtained from the TB laboratory in the Department of 
Medical Microbiology, Tygerberg Hospital. Sputum samples 
were prepared as for routine BACTEC5 analysis and a small 
aliquot was removed for PCR analysis. The liquefied sputum 
sample (up to 0,5 ml) was overlaid on 1 m1 sterile 50% 
sucrose and c e n e e d  at 12 000 g for 5 minutes. The result- 
ing pelleted material was resuspended in sterile saline, cen- 
trifuged at 12 000 g for 10 minutes and the final pellet was 
suspended in 50 pl saline.6 
PCR amplifkation of DNA 
Oligonucleotide primers are described el~ewhere.~ For 
amplification, a 10 pl sample of the saline suspension was 
combined in a total volume of 99 pl of a premixture contain- 
ing 1 X PCR buffer (10 mM tris-HC1 (pH 9,O at 25"C), 
1,5 mM MgCl,, 50 mM KCl, 0,O 1% gelatin, 0,O 1% Triton X- 
loo), 200 ph4 each of dATP, dGTP, dCTP and dTTP and 
primers of 0,4 ph4 each. The reaction mixtures were heated at 
95°C for 5 minutes to lyse cells and denature DNA. Taq poly- 
merase (1 unit) was added, the mixture overlaid with 40 pl 
mineral oil and a heating cycle of 93°C for 1 minute, 68°C for 
1 minute and 72°C for 2 minutes was repeated 30 times in a 
PCR machine built in our own laboratories. Re-amplification 
of negative samples was done by taking a 5 pl aliquot of previ- 
ously amplified material and initiating a new PCR cycle in a 
separate tube and mixture. 
Detection of product 
The amplified DNA product was visualised after gel elec- 
trophoresis on 12% polyacrylamide or 1,7% agarose gels by 
- 
ethidium bromide staining and W transillumination. A 123 
base-pair fragment is detectable after PCR amplification of 
M. tubercuIosis DNA.k7 The high degree of specificity of the 
reaction is shown-by the absence of any product fkom amplifi- 
cation of other Myocobactmum species (M. anrium, M. intracel- 
lulare, M. knsan' and M. f h t u m  (result not shown). 
MRC Centre for Molecular and Cellular Biology, Depart- 
ment of Medical Biochemistry, University of Stellenbosch, 
Parowmdlei, CP 
P.D. VAN HELDEN, PH.D. 
R DU TOE, N D MED. TECH. 
A. JORDAAN, N.D. MED. TECH 
T. VICTOR, N.D. MED. TECH. 
Department of Medical Microbiology, University of 
Stellenbosch and Tygerberg Hospital, Parowvallei, CP 
B. TALJAARD, N.H.D. MED. TECH. 
J. PITOUT, MB. CH.B 
Comparative techniques 
Ziehl-Neelsen (ZN) staining for detection of acid-fast bacilli 
and BACTEC culturing was done according to established 
protocols. 
Results 
The results of assays ror me presence of M. tub.+rnJosis using 
the method described here, are shown in Table I. 
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TABLE 1. COMPARISON OF MISTING AND PCR TESTS 
FOR DIAGNOSIS OF M. NBERCULOSIS 
PCR+ PCR- Totals 
BACTEC+ 190 3 193 
ZN+ 
BACTEC - 2 0 2 
192 3 195 
BACTEC+ 9 0 9 
ZN- 
. BACTEC- 0 15 15 
9 15 24 
Totals 201 18 n s  
Samples: Sputum from normal, apparently healthy p e m s  (15) and from putative TB 
patients (204). ZN - Zehl-Neelsen stain; BACTEC - culture system; PCR - as 
described here. Positive and negative reactions to the tests are shown. 
Discussion - 
BACTEC-positive samples numbered 202, of which 199 (sen- 
sitivity 98,5O/0) were also PCR-positive. Of 17 BACTEC-nega- 
tive samples, 15 were PCR-negative (specificity 88,2%). It 
should be noted that the 2 samples that were BACTEC-nega- 
tive and PCR-positive reacted ZN-positive. We suggest the 
possibility of the failure of the BACTEC system in these cases; 
possibly chemotherapy of the patient prior to sampling aEected 
the BACTEC test, which is not able to detect non-dividing 
organisms (e.g. M. mbernJosis in response to drug injury). 
Three BACTEC-positive samples were PCR-negative, 
even after sucrose treatment of sputum. Although this method 
removes most of the Taq polymerase inhibitors, carry-over 
may occur in a small number. Another explanation for this 
discrepancy is a false-positive result due to contamination of 
the BACTEC system, but since all 3 were also ZN-positive, 
this is unlikely, a e s s  the ZN test detected the presence of 
other Mycobactenirm species. 
Twenty-one samples tested PCR-negative on first-stage 
amplification and PCR-positive after second-stage amplifica- 
tion (re-amplification). In the case of PCR-negative sam~les. 
we re-ampliiied only negative samples. However, in a real 
situation, we would recommend routine re-amplification.' 
The PCR tests ye currently being done by a medical tech- 
nologist with no sp&c background experience in DNA tech- 
nology. The test is usually completed in just less than 1,5 days, 
but could be done in 1 day. 
Developments in PCR technology are likely to shorten the 
time even further. This contrasts with results obtained fkom 
culture or BACTEC, which take 8 - 40 days, and has immedi- 
ate implications for patient treatment, particularly as regards 
hospitalisation cost and compliance. Furthermore, the capital 
expenditure is approximately one-fifth (or less) that of the 
BACTEC detection system (approximately R25 000 for PCR 
and R140 000 for BACTEC). The PCR test uses no isotopes 
and costs approximately RIO per test for PCR against approxi- 
mately R85 per test for BACTEC. In addition, the PCR test 
poses fewer hazards and waste-disposal problems. 
The PCR has not been extensively tested in a low-preva- 
lace  situation, such as community screening,'and our results 
suggest that negative predictive value is not yet adequate for 
this use. However, it is clear that in a hospital laboratory situa- 
tion, the PCR test should be considered for wider evaluation 
and use. 
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